MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ofid/ofag216

Медицинская библиотека · Open forum infectious diseases · 2026

The COMEBACK Study: Social Determinants of Health Impact on Virologic Suppression in a 48-Week Low-Barrier-Care Study of Rapid Antiretroviral Therapy Reinitiation Among Persons With HIV Lost to Care.

Huhn Gregory D, Osborn Rebecca, Roden Lindsey, Keckler Kody, DeMarco Camille, Valadez Patricia Cortes

Клиническое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Effectively preventing transmission is critical to ending the HIV epidemic (EHE). The primary objective of the COMEBACK study, a 48-week single-center study, was to reengage lost-to-care persons with HIV and rapidly reinitiate antiretroviral therapy (ART) with bictegravir/emtricitabine/tenofovir alefenamide (B/F/TAF) in a low-barrier-care model to promote virologic suppression (VS).

METHODS

Adults off ART for ≥2 weeks, without significant B/F/TAF resistance or renal impairment, were started on B/F/TAF upon reengagement after same-day baseline labs (n = 100). Participants self-screened into case management (CM) tiers: minimal, moderate, or advanced. Participants requiring additional support (tier escalation) were identified during the study. The associations of baseline characteristics and 5 social determinants of health (SDoH) assessments with VS status at study end were analyzed.

RESULTS

At baseline, the median age was 37 years, with 90% Black and 68% cisgender male. Median CD4+ was 310 cells/mm3, with a median viral load of 11 084 copies/mL (16% VS). Median time off ART was 5 months. Fifty-nine of 100 participants required tier escalation. Sixty-six of 100 participants were retained in care at 48 weeks, with VS (HIV-1 RNA <200 copies/mL) in 54% of the intent-to-treat population and 82% (n = 54/66) of the observed population. One SDoH (adherence concerns) was significantly associated with non-VS. No resistance to B/F/TAF was detected through 48 weeks.

CONCLUSIONS

VS was high for participants with rapid ART reinitiation retained in care. CM escalation and baseline adherence concerns were associated with non-VS at study end. Achieving VS among high-risk populations disenfranchised from care will likely require further innovation in intense individualized CM and retention approaches to capitalize on low-barrier-care models toward EHE.

Для цитирования: Huhn Gregory D, Osborn Rebecca, Roden Lindsey, Keckler Kody, DeMarco Camille, Valadez Patricia Cortes. The COMEBACK Study: Social Determinants of Health Impact on Virologic Suppression in a 48-Week Low-Barrier-Care Study of Rapid Antiretroviral Therapy Reinitiation Among Persons With HIV Lost to Care.. Open forum infectious diseases. 2026. DOI: 10.1093/ofid/ofag216.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.